Centre asks MSME drugmakers to submit action plans on quality compliance in 3 months or risk closure
The decision comes in the wake of the Centre’s plan to extend the deadline for small pharmaceutical companies – with revenue of ₹250 crore or less – to comply with GMP by one year to 31 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback